Prolutex in Frozen Embryo Transfer Cycles at the Blastocyst Stage (PROGEX) NCT03701490

What is studied: It is the first clinical trial in the world to use Progesterone administered subcutaneously at a dose of 50 mg daily and compares it with standard vaginal administration.

Aim: We want to know the optimal treatment protocol that can improve the results through the administration route of the medication of patients who receive frozen embryos. 

Start: March 2020

Location: Instituto Bernabeu Alicante

More information: For more information click here

For study details you can find them through the link